You are currently viewing Noble Trial

Noble Trial

EBC - ON DEMAND

Noble Trial

European Bifurcation Club 2010, EBC 2010 – Budapest, Hungary

LM upcoming studies: place of techniques?

Noble Trial

Author: Leif Thuesen, MD, Aarhus University Hospital, Skejby, Denmark

 

PURPOSE

In a clinical, randomized, 5-year follow-up study to compare essential clinical outcome parameters in patients with unprotected left main (LMCA) disease, treated with coronary artery bypass grafting versus percutaneous coronary intervention using drug eluting stents.

STUDY HYPOTHESIS

DES-PCI of unprotected LMCA disease is non-inferior to CABG concerning the 2-year rate of death, myocardial infarction, stroke or new revascularization.

 

Download here

Leave a Reply